☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Teva Pharmaceuticals
Teva Reports Results from the P-III Study of Ajovy (fremanezumab) to Prevent Migraine in Chinese Patients
April 12, 2024
PharmaShots Weekly Snapshots (April 01 – April 05, 2024)
April 5, 2024
Teva Pharmaceuticals and mAbxience Join Hands to Develop Biosimilar Candidates for Treating Oncology Indications
April 5, 2024
Teva Pharmaceuticals Reports the Results of Uzedy in P-III Trial as an Extended-Release Injectable Suspension for Schizophrenia
November 2, 2023
Load more...
Back to Home